Díaz GJL, Jauma RA, Triana CI, Insua AC, Franco AO

Language: Spanish
References: 25
Page: 51-58
PDF size: 96.69 Kb.

ABSTRACT

Introduction: ocular allergy is a disease that frequently presents in clinical practice in ophthalmology.
Objectives: to characterize the pediatric patients with allergic conjunctivitis of the ophthalmological service of "William Soler" hospital.
Methods: a prospective, observational and descriptive study was conducted in 2010 and 2011; the universe of study was the patients with presumptive diagnosis of allergic conjunctivitis and the sample was made up of 80 patients after the application of inclusion and exclusion criteria. The analyzed variables were age, sex, race, clinical presentation and associated risk factors. Descriptive statistics (absolute frequencies and percentages) were used.
Results: children aged 8 to 13 years (68.8 %) were predominant, followed by those of 3 to 7 years (12.5 %) and 14 to 18 years (1.9 %), males (72.5 %) and Caucasians (71.2 %). The most common clinical type of allergic conjunctivitis was the seasonal and permanent one (38.8 %), followed by the acute one (31.3 %) and the least observed was contact dermatoconjunctivitis (5 %). Exposure to dust was mentioned in 100 % of patients.
Conclusions: children aged 8 to 13 years, males and Caucasians prevailed. The most frequent clinical type of allergic conjunctivitis was the seasonal and perennial one and the associated risk factor was exposure to dust.

REFERENCES

1. Mantelli F, Lambiase A, Bonini S, Bonini S. Clinical trials in allergic conjunctivits: a systematic review. Allerg & Clinical Immunol. 2011;66(7):919-24.

2. Rivas Fernández MA. Alérgenos aéreos: rinitis y conjuntivitis atópica [monografía en Internet]. San Salvador: Universidad Central del Salvador; 2010 [citado 16 de agosto de 2011]. Disponible en: http://imb.usal.es/formacion/docencia/alergenos/trabajos%20de%20alergenos- 06/Al%E9rgenos%20%20a%E9reos.pdf

3. Olivé González MM. Práctica médica en Oftalmología. La Habana: Editorial Ciencias Médicas; 2008. p. 17.

4. Gil Gibernau JJ. Oftalmología en la infancia. Clínica. Diagnóstico y Tratamiento. Barcelona: Scriba S.A.; 2009. p. 58-67.

5. Coscostegui Guraya B. Ponencia de la Sociedad Española de Oftalmología. Universidad de Santiago de Compostela: Coordinación Implementos Universitarios; 2009. p. 2-6.

6. Declaración de Helsinki enmendada por la 52a Asamblea General en Edimburgo, Escocia 2000 [monografía en Internet]. Ginebra: ONU; 2000 [citado 16 de agosto de 2011]. Disponible en: http://www.wma.net/e/policy/b3.html

7. Rosario N, Bielory L. Epidemiology of allergic conjunctivitis. Current Opinion Allergy & Clinical Immunol. 2011;11(5):471-6.

8. O'Shea JG. A survey of vernal keratoconjunctivitis and other eosinophil-mediated external eye diseases amongst Palestinians. Ophtalmic Epidemiol. 2000;7(2):149-57.

9. Berdy GJ, Hedqvist B. Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management. Acta Ophthalmol Scand Suppl. 2000;78(Suppl 230):32-7.

10. Mishra GP, Tamboli V, Jwala J, Mitra AK. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis. Inflamm Allergy Drug Discov. 2011;5(1):26-36.

11. Sutphin JE. Basic and Clinical Sciences Course: External Diseases and Cornea. San Francisco, CA: American Academy of Ophthalmology; 2008. p. 161-73.

12. Nishimura A, Campbell-Meltzer RS, Chute K, Orrell J, Ono SJ. Genetics of allergic disease: evidence for organ-specific susceptibility genes. Int Arch Allergy Immunol. 2001;124(1-3):197-200.

13. Toda M, Ono SJ. Genomics and proteomics of allergic disease. Immunology. 2002;106(1):1-10.

14. Offiah I, Calder VL. Immune mechanisms in allergic eye diseases: what is new? Curr Opin Allergy Clin Immunol. 2009;9(5):477-81.

15. Belfort R, Marbeck P, Hsu CC, Freitas D. Epidemiological study of 134 subjects with allergic conjunctivitis. Acta Ophtalmol Scan. 2000;78(Suppl 230):38-40.

16. Bielory L. Allergic and immunologic disorders of the eye. En: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW eds. Allergy: principles and practice. 4th ed. St. Louis: Mosby-Year Book; 1993. p. 1148-61.

17. Abu El-Asrar AM, Struyf S, Al-Kharashi SA, Missotten L, Van Damme J, Geboes K. Expression of T lymphocyte chemoattractants and activation markers in vernal keratoconjunctivitis. Br J Ophthalmol. 2002;86(10):1175-80.

18. DiGioacchino M, Cavallucci E, DiSciascio MB, DiStefano F, Verna N, Lobefalo L, et al. Increase in CD45RO+ cells and activated eosinophils in chronic allergic conjunctivitis. Immunobiology. 2000;201(5):541-51.

19. Ebihara N, Okumura K, Nakayasu K, Kanai A, Ra C. High level of Fc epsilon receptor I-bindable immunoglobulin E in the tear fluid and increased immunoglobulin E-saturated cells in the giant papillae of vernal keratoconjunctivitis patients. Jpn J Ophthalmol. 2002;46(4):357-63.

20. Watelet JB, McGill JI, Pawankar R, Church DS, Church MK. Allergic rhinitis and conjunctivitis: update on pathophysiology. Allergy Frontiers. 2009;3:1-23.

21. Strauss EC, Foster CS. Atopic ocular disease. Ophthalmol Clin North Am. 2002;15(1):1-5.

22. Uchio E, Ono SY, Ikezawa Z, Ohno S. Tear levels of interferon-gamma, interleukin (IL)-2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis. Clin Exp Allergy. 2000;30(1):103-9.

23. Torres Galván M, Quiralte J, Pestano JJ, Ortega N, Blanco C, Castillo R, et al. IL4- R1 (5q31-q33) and FceRI-ca (11q13) markers and atopy: a case/control study in a Spanish population. Allergy & Clinical Immunol. 2001;56(2):159-63.

24. Sim CS, Kim Y, Yoo CI, Suh HS, Oh IB, Lee JH. The relationship between atopic diseases and relating factors in urban elementary school children. Epidemiology. 2011;22(1):171-5.

25. del Cuvillo A, Sastre J, Montoro J, Jáuregui I, Dávila I, Ferrer M, et al. Allergic conjunctivitis and H1 antihistamines. J Investig Allergol Clin Immunol. 2009;19(Suppl 1):11-8.